testosterone undecanoate: Clinical Trials

25 trials of testosterone undecanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 25 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 225Completed 18, Not yet recruiting 2, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1
Phase 33Completed 3
Phase 12Completed 1, Unknown 1

Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency
Nebido (Testosterone Undecanoate) - Frail Elderly Patients, Hypogonadal Males
Phase 2Not yet recruitingRune Skovgaard Rasmussen962026-08-012026-05-06
An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD
Oral Testosterone Undecanoate - Hypoactive Sexual Desire Disorder
Phase 2Not yet recruitingSan Diego Sexual Medicine302025-01-012024-11-13
Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?
Saline, Testosterone Undecanoate, Saline + Resistance exercise training - Healthy Aging, Age-Related Sarcopenia
Phase 2 / Phase 3CompletedNorwegian School of Sport Sciences452024-09-012026-03-06
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male
Phase 1 / Phase 2UnknownUniversity of Washington102024-06-012024-03-15
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Testosterone Undecanoate, Enzalutamide - Prostate Cancer, Castration-resistant Prostate Cancer
Phase 2Active not recruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins152022-03-072026-09-29
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
Testosterone Undecanoate 250 MG/ML, Placebo - Opioid Use, Pain
Phase 2RecruitingBrigham and Women's Hospital1502022-01-102026-07-27
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], placebo - Hypogonadism, Male, Fatigue Syndrome, Chronic
Phase 2RecruitingSeattle Institute for Biomedical and Clinical Research2402021-03-222026-06-22
A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial
LPCN 1144 - NASH - Nonalcoholic Steatohepatitis
Phase 2CompletedLipocine Inc.252020-11-112024-07-17
The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
LPCN 1144 Formulation A, LPCN 1144 Formulation B, Placebo - Nonalcoholic Steatohepatitis (NASH)
Phase 2CompletedLipocine Inc.562019-08-272023-12-14
Multimodality Intervention for Function and Metabolism in SCI
Testosterone Undecanoate, hybrid exercise - Spinal Cord Injuries
Phase 2CompletedBrigham and Women's Hospital842019-08-232026-05-07
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
Oral Testosterone Undecanoate - Hypogonadism
Phase 2CompletedClarus Therapeutics, Inc.182016-10-012018-05-17
Testosterone in Metastatic Renal Cell Carcinoma Patients
Testosterone undecanoate and sunitinib or pazopanib - Metastatic Renal Cell Carcinoma
Phase 2CompletedKidney Cancer Research Bureau602016-02-082019-10-22
Phlebotomy Study of Testosterone Undecanoate
Oral Testosterone Undecanoate - Hypogonadism
Phase 1 / Phase 2CompletedClarus Therapeutics, Inc.82016-01-012018-03-09
Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
testosterone undecanoate - Nonalcoholic Steatohepatitis, Hypogonadism
Phase 2CompletedSheffield Teaching Hospitals NHS Foundation Trust32013-07-012017-04-26
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
Testosterone undecanoate, placebo - Female Sexual Dysfunction
Phase 2CompletedChulalongkorn University702012-06-012014-01-29
Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients
Testosterone undecanoate, placebo - Multiple Sclerosis, Fatigue
Phase 2TerminatedHealth Sciences Centre, Winnipeg, Manitoba32012-02-012014-07-08
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
Oral testosterone undecanoate (containing 300 mg T) - Male Hypogonadism
Phase 2CompletedClarus Therapeutics, Inc.162009-07-012020-12-02
Pharmacokinetic Study to Determine Time to Steady-state
Testosterone undecanoate - Male Hypogonadism, Primary Hypogonadism
Phase 2CompletedClarus Therapeutics, Inc.152009-07-012020-12-11
Androgen for Leydig Cell Proliferation
Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism
Phase 2 / Phase 3CompletedUniversity of Roma La Sapienza562009-06-012018-09-25
Reandron in Diabetic Men Witn Low Testosterone Level
Reandron 1000, placebo - Type 2 Diabetes, Hypogonadism
Phase 2 / Phase 3CompletedAustin Health882009-01-012014-07-01

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Hypogonadism (13)  ·  Eunuchism (7)  ·  Non-alcoholic Fatty Liver Disease (3)  ·  Carcinoma, Renal Cell (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fatigue (1)  ·  Fatigue Syndrome, Chronic (1)  ·  Frailty (1)  ·  Infertility (1)  ·  Klinefelter Syndrome (1)  ·  Multiple Sclerosis (1)  ·  Pain (1)  ·  Prostatic Neoplasms (1)  ·  Sexual Dysfunctions, Psychological (1)

Sponsors

Clarus Therapeutics, Inc. (6)  ·  Brigham and Women's Hospital (2)  ·  Lipocine Inc. (2)  ·  Austin Health (1)  ·  Chulalongkorn University (1)  ·  Health Sciences Centre, Winnipeg, Manitoba (1)  ·  Imperial College London (1)  ·  Kidney Cancer Research Bureau (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Norwegian School of Sport Sciences (1)  ·  Organon and Co (1)  ·  Rune Skovgaard Rasmussen (1)  ·  San Diego Sexual Medicine (1)  ·  Seattle Institute for Biomedical and Clinical Research (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)

Countries

United States (13)  ·  Canada (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Denmark (1)  ·  Italy (1)  ·  Norway (1)  ·  Russia (1)  ·  Thailand (1)

Top investigators

Anthony DelConte (2)  ·  Andrea Isidori, MD, PhD (1)  ·  Andrea Lenzi, MD (1)  ·  Christina Wang, M.D. (1)  ·  Dermot Gleeson, MD (1)  ·  Gregory Flippo, M.D. (1)  ·  Gregory Flippo, MD (1)  ·  Irwin Goldstein, MD (1)  ·  James J Marriott, MD (1)  ·  John Amory, MD (1)  ·  Jose M Garcia, MD, PhD (1)  ·  Mathis Grossmann (1)  ·  Mette Midttun, MD, DMSc (1)  ·  Peter Collins, MA MD FRCP (1)  ·  Reuthairat Tungmunsakulchai, MD (1)

Results publications

PMID 21474786, PMID 12626215, PMID 18308009, PMID 18413423, PMID 23581697, PMID 24978674, PMID 26030346, PMID 26631095, PMID 31532522, PMID 35614404, PMID 38325649

NIH funding

R01HD093724 (1)